Literature DB >> 23600546

Development of atopic disease and disturbed sleep in childhood and adolescence--a longitudinal population-based study.

S Jernelöv1, M Lekander, C Almqvist, J Axelsson, H Larsson.   

Abstract

BACKGROUND: Both atopic diseases and sleep disturbances have increased during recent decades, especially in children. Sleep is important for many aspects of immune regulation relevant in allergic diseases, and sleep disturbances are common in patients with such diseases. A connection between sleep disturbances and fatigue, and atopic disease is well established. However, the time course and putative causal relationships between these factors are obscure.
OBJECTIVE: We aimed at investigating the developmental relationships between subjectively reported sleep disturbances and symptoms of atopic disease, from childhood to adolescence.
METHODS: This longitudinal study used parent-report questionnaire data on symptoms of atopic disease, and sleep disturbances, from the Twin Study of Child and Adolescent Development (TCHAD). Overall, 1480 twin pairs born in Sweden were approached first when children were 8-9 years old, and again later at 13-14 years old. Response rates were 75% and 72%. Data from the TCHAD questionnaires were linked to the Swedish Medical Birth Register based on personal identification numbers.
RESULTS: Being overtired at age 8 increased the risk [OR; 95% CI (2.59; 1.31-5.11)] to develop rhinitis symptoms at age 13, even when controlling for gender, previous rhinitis, Socio-economic status, birth weight and other sleep disturbances at age 8. Likewise, symptoms of asthma at age 8 was an independent risk factor for being overtired at age 13 [OR; 95% CI (2.64; 1.44-4.84)], controlling for similar confounders. CONCLUSION & CLINICAL RELEVANCE: The findings from this study are consonant with the proposition that atopic disease and disturbed sleep are more than passively interrelated. Future research needs to delineate whether causal relationships between these problems are at hand and, if so, at what periods in development this applies. These results point to a need for clinicians to investigate sleep difficulties and treat impaired sleep in paediatric patients with atopic disease.
© 2013 Blackwell Publishing Ltd.

Entities:  

Mesh:

Year:  2013        PMID: 23600546     DOI: 10.1111/cea.12087

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  6 in total

1.  Associations of sleep problems with asthma and allergic rhinitis among Chinese preschoolers.

Authors:  Ying Ma; Jie Tang; Yuqi Wen; Yan Hu; Jingjing Liang; Lin Jiang; Yanfei Xing; Yanyan Song
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

2.  The association between allergic rhinitis and sleep: A systematic review and meta-analysis of observational studies.

Authors:  Jiaomei Liu; Xinge Zhang; Yingying Zhao; Yujiao Wang
Journal:  PLoS One       Date:  2020-02-13       Impact factor: 3.240

3.  Academic achievement of adolescents with asthma or atopic disease.

Authors:  Bronwyn K Brew; Joakim Söderberg; Cecilia Lundholm; Soren Afshar; Kirsten Holmberg; Catarina Almqvist
Journal:  Clin Exp Allergy       Date:  2019-03-06       Impact factor: 5.018

4.  Asthma and subsequent school performance at age 15-16 years: A Swedish population-based sibling control study.

Authors:  Cecilia Lundholm; Bronwyn K Brew; Brian M D'Onofrio; Emma Caffrey Osvald; Henrik Larsson; Catarina Almqvist
Journal:  Sci Rep       Date:  2020-05-06       Impact factor: 4.379

5.  Associations of sleep characteristics with atopic disease: a cross-sectional study among Chinese adolescents.

Authors:  Yiting Chen; Qian Yang; Kena Zhao; Zengqiang Wu; Xiaoming Shen; Shenghui Li
Journal:  Allergy Asthma Clin Immunol       Date:  2021-02-22       Impact factor: 3.406

6.  What Is the Role of Night-Time Noise Exposure in Childhood Allergic Disease?

Authors:  A-Ram Kim; Jin-Hee Bang; Sung-Hee Lee; Jiho Lee
Journal:  Int J Environ Res Public Health       Date:  2022-02-26       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.